Table 2.
Predictors of TM use
| First author (year) | Factors | Predictors, mean OR (95% CI) |
|---|---|---|
| Sociodemographic | ||
| Ali (2014)15 | Gender | Female: 2.12 (1.86–4.33) |
| Chetoui (2021)29 | Female: 2.064 (1.417−3.008) | |
| Kifle (2021)30 | Female: 1.98 (1.72–3.25) | |
| Chetty (2022)33 | Female: 1.31 (0.75–2.78) | |
| Ali (2014)15 | Residency | Rural: 1.48 (0.74–2.81) |
| Kifle (2021)30 | Rural: 2.34 (1.82–3.29) | |
| Chetoui (2021)29 | Urban: 1.684 (1.123−2.525) | |
| Ali (2014)15 | Education | Tertiary: 0.38 (0.22–1.28) |
| Kifle (2021)30 | Tertiary: 1.54 (1.32–2.08) | |
| Mekuria (2018)23 | Tertiary: 1.72 (1.18–5.12) | |
| Secondary: 1.90 (0.79–4.92) | ||
| Chetty (2022)33 | Age | 60–75 y: 1.32 (0.78–2.24) |
| >75 y: 1.42 (0.67–3.01) | ||
| Health related | ||
| Chetoui (2021)29 | Diabetes duration | >5 y: 1.429 (1.031−1.980) |
| Kifle (2021)30 | >5 y: 2.53 (1.45–4.67) | |
| Mekuria (2018)23 | >6 y: 1.51 (1.31–4.79) | |
| Ali (2014)15 | >8 y: 4.06 (2.79–5.6) | |
| Amaeze (2018)22 | >20 y: 3.015 (1.361–6.679) | |
| Amaeze (2018)22 | Diabetes management | Oral: 1.784 (1.141–2.789) |
| Chetoui (2021)29 | Oral: 1.805 (1.227−2.657) | |
| Oral+insulin: 1.881 (1.188−2.977) | ||
| Kifle (2021)30 | Family history of diabetes | 2.89 (1.42–3.19) |
| Mekuria (2018)23 | 3.12 (1.62–8.05) | |